244 related articles for article (PubMed ID: 30292104)
1. Tannic acid-inspired paclitaxel nanoparticles for enhanced anticancer effects in breast cancer cells.
Chowdhury P; Nagesh PKB; Hatami E; Wagh S; Dan N; Tripathi MK; Khan S; Hafeez BB; Meibohm B; Chauhan SC; Jaggi M; Yallapu MM
J Colloid Interface Sci; 2019 Feb; 535():133-148. PubMed ID: 30292104
[TBL] [Abstract][Full Text] [Related]
2. Hydrogen-Bonded Tannic Acid-Based Anticancer Nanoparticle for Enhancement of Oral Chemotherapy.
Le Z; Chen Y; Han H; Tian H; Zhao P; Yang C; He Z; Liu L; Leong KW; Mao HQ; Liu Z; Chen Y
ACS Appl Mater Interfaces; 2018 Dec; 10(49):42186-42197. PubMed ID: 30444601
[TBL] [Abstract][Full Text] [Related]
3. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel Nanoparticles Induce Apoptosis and Regulate TXR1, CYP3A4 and CYP2C8 in Breast Cancer and Hepatoma Cells.
Diab T; Alkafaas SS; Shalaby TI; Hessien M
Anticancer Agents Med Chem; 2020; 20(13):1582-1591. PubMed ID: 32364081
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel-loaded star-shaped copolymer nanoparticles for enhanced malignant melanoma chemotherapy against multidrug resistance.
Su Y; Hu J; Huang Z; Huang Y; Peng B; Xie N; Liu H
Drug Des Devel Ther; 2017; 11():659-668. PubMed ID: 28293102
[TBL] [Abstract][Full Text] [Related]
6. Green synthesis, formulation and biological evaluation of a novel ZnO nanocarrier loaded with paclitaxel as drug delivery system on MCF-7 cell line.
Akbarian M; Mahjoub S; Elahi SM; Zabihi E; Tashakkorian H
Colloids Surf B Biointerfaces; 2020 Feb; 186():110686. PubMed ID: 31816463
[TBL] [Abstract][Full Text] [Related]
7. Targeted Nanostructured Lipid Carriers for Delivery of Paclitaxel to Cancer Cells: Preparation, Characterization, and Cell Toxicity.
Rezazadeh M; Emami J; Hassanzadeh F; Sadeghi H; Rostami M; Mohammadkhani H
Curr Drug Deliv; 2017; 14(8):1189-1200. PubMed ID: 28472908
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone simulates the anticancer effect of nano-formulated paclitaxel in breast cancer cells.
Diab T; AlKafaas SS; Shalaby TI; Hessien M
Bioorg Chem; 2020 Jun; 99():103792. PubMed ID: 32240873
[TBL] [Abstract][Full Text] [Related]
9. Polymeric Nanomedicine for Combined Gene/Chemotherapy Elicits Enhanced Tumor Suppression.
Xu B; Xia S; Wang F; Jin Q; Yu T; He L; Chen Y; Liu Y; Li S; Tan X; Ren K; Yao S; Zeng J; Song X
Mol Pharm; 2016 Feb; 13(2):663-76. PubMed ID: 26695934
[TBL] [Abstract][Full Text] [Related]
10. Anticancer activity of paclitaxel-loaded keratin nanoparticles in two-dimensional and perfused three-dimensional breast cancer models.
Foglietta F; Spagnoli GC; Muraro MG; Ballestri M; Guerrini A; Ferroni C; Aluigi A; Sotgiu G; Varchi G
Int J Nanomedicine; 2018; 13():4847-4867. PubMed ID: 30214193
[TBL] [Abstract][Full Text] [Related]
11. Folic Acid-Modified Nanoerythrocyte for Codelivery of Paclitaxel and Tariquidar to Overcome Breast Cancer Multidrug Resistance.
Zhong P; Chen X; Guo R; Chen X; Chen Z; Wei C; Li Y; Wang W; Zhou Y; Qin L
Mol Pharm; 2020 Apr; 17(4):1114-1126. PubMed ID: 32176509
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel-betulinic acid hybrid nanosuspensions for enhanced anti-breast cancer activity.
Wang R; Yang M; Li G; Wang X; Zhang Z; Qiao H; Chen J; Chen Z; Cui X; Li J
Colloids Surf B Biointerfaces; 2019 Feb; 174():270-279. PubMed ID: 30469048
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary Delivery of Reactive Oxygen Species/Glutathione-Responsive Paclitaxel Dimeric Nanoparticles Improved Therapeutic Indices against Metastatic Lung Cancer.
Tian X; Bera H; Guo X; Xu R; Sun J; He Z; Cun D; Yang M
ACS Appl Mater Interfaces; 2021 Dec; 13(48):56858-56872. PubMed ID: 34806372
[TBL] [Abstract][Full Text] [Related]
14. Self-assembly of biotinylated poly(ethylene glycol)-poly(curcumin) for paclitaxel delivery.
Hu L; Li M; Zhang Z; Shen Y; Guo S
Int J Pharm; 2018 Dec; 553(1-2):510-521. PubMed ID: 30308274
[TBL] [Abstract][Full Text] [Related]
15. Novel self-assembly endows human serum albumin nanoparticles with an enhanced antitumor efficacy.
Ding D; Tang X; Cao X; Wu J; Yuan A; Qiao Q; Pan J; Hu Y
AAPS PharmSciTech; 2014 Feb; 15(1):213-22. PubMed ID: 24287627
[TBL] [Abstract][Full Text] [Related]
16. Vitamin E-Oligo(methyl diglycol l-glutamate) as a Biocompatible and Functional Surfactant for Facile Preparation of Active Tumor-Targeting PLGA Nanoparticles.
Wu J; Zhang J; Deng C; Meng F; Zhong Z
Biomacromolecules; 2016 Jul; 17(7):2367-74. PubMed ID: 27305935
[TBL] [Abstract][Full Text] [Related]
17. In vitro evaluation of paclitaxel loaded amorphous chitin nanoparticles for colon cancer drug delivery.
Smitha KT; Anitha A; Furuike T; Tamura H; Nair SV; Jayakumar R
Colloids Surf B Biointerfaces; 2013 Apr; 104():245-53. PubMed ID: 23337120
[TBL] [Abstract][Full Text] [Related]
18. Development of paclitaxel loaded pegylated gelatin targeted nanoparticles for improved treatment efficacy in non-small cell lung cancer (NSCLC): an in vitro and in vivo evaluation study.
Gu M; Luan J; Song K; Qiu C; Zhang X; Zhang M
Acta Biochim Pol; 2021 Aug; 68(4):583-591. PubMed ID: 34355554
[TBL] [Abstract][Full Text] [Related]
19. Effect of Paclitaxel-Loaded PLGA Nanoparticles on MDA-MB Type Cell Lines: Apoptosis and Cytotoxicity Studies.
Vijayan V; Shalini K; Yugesvaran V; Yee TH; Balakrishnan S; Palanimuthu VR
Curr Pharm Des; 2018; 24(28):3366-3375. PubMed ID: 30179118
[TBL] [Abstract][Full Text] [Related]
20. Enhanced intracellular delivery and controlled drug release of magnetic PLGA nanoparticles modified with transferrin.
Cui YN; Xu QX; Davoodi P; Wang DP; Wang CH
Acta Pharmacol Sin; 2017 Jun; 38(6):943-953. PubMed ID: 28552909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]